Biotech CFO Role – Philadelphia



August 10, 2020


Northwest Philadelphia


2 Drugs in phase 3, will be public and revenue generating in 90 days

2021 revenues conservatively estimated at $3 billion

On run rate to increase value by 1768% – company valuation has already increased $340 million over last 10 days  w/o

COVID-19 fast track designation for drugs shown to reduce COVID-19 ventilator patient mortality rate from 80% to under 10%

Drugs target specific lung cells – no other proposed treatments target these cells

Suicidal Bipolar Depression – estimated market of $2.2 billion annually (per IQVIA ) patented with no approved drugs in the space – exclusivity for 12 Years

Awarded Breakthrough Therapy Designation (FDA) and SPA


Newly created position that reports to and will be a true business partner to the CEO

Highly Strategic role responsible for maximizing company value, commercialization strategy, M&A, business strategy & planning, audit oversight, investor relations, and treasury


Our client is looking for the best and brightest biotech CFO available – a strong key player with exceptional credentials and stellar background who is at the top of their game and at the height of their career

Proven track record within the biotech industry of generating above average shareholder returns

Public company CFO experience in Biotech or Pharma, Top tier MBA or CPA strongly preferred

Public company exit a plus

Referral Bonus*

If you or someone you know has an interest in learning more please contact our offices immediately. If you refer someone we place in the role we are offering a $2,500 Referral Bonus.

Back to CFO Jobs Page